Dana C. Borcherding

940 total citations
25 papers, 533 citations indexed

About

Dana C. Borcherding is a scholar working on Molecular Biology, Physiology and Oncology. According to data from OpenAlex, Dana C. Borcherding has authored 25 papers receiving a total of 533 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Physiology and 5 papers in Oncology. Recurrent topics in Dana C. Borcherding's work include Diet and metabolism studies (4 papers), Adipose Tissue and Metabolism (4 papers) and Cancer, Stress, Anesthesia, and Immune Response (3 papers). Dana C. Borcherding is often cited by papers focused on Diet and metabolism studies (4 papers), Adipose Tissue and Metabolism (4 papers) and Cancer, Stress, Anesthesia, and Immune Response (3 papers). Dana C. Borcherding collaborates with scholars based in United States and South Korea. Dana C. Borcherding's co-authors include Nira Ben‐Jonathan, Eric R. Hugo, Albert E. Jergens, Jonathan P. Mochel, Karin Allenspach, Yoko M. Ambrosini, Hyun Jung Kim, Gila Idelman, Auriel A. Willette and Anumantha G. Kanthasamy and has published in prestigious journals such as Journal of Clinical Investigation, Gastroenterology and PLoS ONE.

In The Last Decade

Dana C. Borcherding

23 papers receiving 524 citations

Peers

Dana C. Borcherding

ONCOL

PHYSI

PRM

EDM

Kuo Zhang China

Qianquan Ma China

Jennifer M. Brazill United States

Takehisa Hirayama Japan

Tamás Kovács Hungary

Christiane Elisabeth Sørensen Denmark

Ashish Kumar India

Anthony G. Mansour United States

Lingyan Zhou China

Kuo Zhang China

Dana C. Borcherding

218 ×1.1

84 ×0.7

ONCOL

82 ×0.8

PHYSI

47 ×0.6

PRM

43 ×0.6

EDM

Citations per year, relative to Dana C. Borcherding Dana C. Borcherding (= 1×) peers Kuo Zhang

Countries citing papers authored by Dana C. Borcherding

Since Specialization

Citations

This map shows the geographic impact of Dana C. Borcherding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dana C. Borcherding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dana C. Borcherding more than expected).

Fields of papers citing papers by Dana C. Borcherding

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dana C. Borcherding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dana C. Borcherding. The network helps show where Dana C. Borcherding may publish in the future.

Co-authorship network of co-authors of Dana C. Borcherding

This figure shows the co-authorship network connecting the top 25 collaborators of Dana C. Borcherding. A scholar is included among the top collaborators of Dana C. Borcherding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dana C. Borcherding. Dana C. Borcherding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Borcherding, Dana C., Yang Lyu, Anthony P.W. Yuen, et al.. (2025). MTA-Cooperative PRMT5 Inhibitors Are Efficacious in MTAP-Deleted Malignant Peripheral Nerve Sheath Tumor Models. Clinical Cancer Research. 31(22). 4779–4789.

Davoudi, Zahra, Todd Atherly, Dana C. Borcherding, et al.. (2023). Study Transportation of Drugs within Newly Established Murine Colon Organoid Systems. Advanced Biology. 7(12). e2300103–e2300103. 5 indexed citations

Borcherding, Dana C., Xiaochun Zhang, Minjie Zhang, et al.. (2023). EXTH-63. MTA-COOPERATIVE PRMT5 INHIBITORS ARE EFFICACIOUS IN MTAP-DELETED MALIGNANT PERIPHERAL NERVE SHEATH TUMOR MODELS. Neuro-Oncology. 25(Supplement_5). v238–v238. 3 indexed citations

Borcherding, Dana C., Yang Lyu, Carina Dehner, et al.. (2023). MEK Inhibition Synergizes with TYK2 Inhibitors in NF1-Associated Malignant Peripheral Nerve Sheath Tumors. Clinical Cancer Research. 29(8). 1592–1604. 14 indexed citations

Ben‐Jonathan, Nira, Dana C. Borcherding, & Eric R. Hugo. (2022). Dopamine Receptors in Breast Cancer: Prevalence, Signaling, and Therapeutic Applications. Critical Reviews™ in Oncogenesis. 27(2). 51–71.

Sahoo, Dipak Kumar, Dana C. Borcherding, Lawrance C. Chandra, et al.. (2022). Differential transcriptomic profiles following stimulation with lipopolysaccharide in intestinal organoids from dogs with inflammatory bowel disease and intestinal mast cell tumor. Zenodo (CERN European Organization for Nuclear Research). 1 indexed citations

Sahoo, Dipak Kumar, Dana C. Borcherding, Lawrance C. Chandra, et al.. (2022). Differential Transcriptomic Profiles Following Stimulation with Lipopolysaccharide in Intestinal Organoids from Dogs with Inflammatory Bowel Disease and Intestinal Mast Cell Tumor. Cancers. 14(14). 3525–3525. 30 indexed citations

Borcherding, Dana C., Eric R. Hugo, Sejal R. Fox, et al.. (2021). Suppression of Breast Cancer by Small Molecules That Block the Prolactin Receptor. Cancers. 13(11). 2662–2662. 13 indexed citations

Ambrosini, Yoko M., Yejin Park, Albert E. Jergens, et al.. (2020). Recapitulation of the accessible interface of biopsy-derived canine intestinal organoids to study epithelial-luminal interactions. PLoS ONE. 15(4). e0231423–e0231423. 44 indexed citations

10.

Ambrosini, Yoko M., Sebastian Neuber, Dana C. Borcherding, et al.. (2020). Treatment With Hydrolyzed Diet Supplemented With Prebiotics and Glycosaminoglycans Alters Lipid Metabolism in Canine Inflammatory Bowel Disease. Frontiers in Veterinary Science. 7. 451–451. 16 indexed citations

11.

Borcherding, Dana C., Todd Atherly, Agnes Bourgois‐Mochel, et al.. (2020). Sa1976 POLYPHENOLS REVERSE THE PATHOLOGIC EFFECTS OF PALMITIC ACID AND HIGH FAT DIET IN CANINE ENTEROIDS. Gastroenterology. 158(6). S–486. 1 indexed citations

12.

Borcherding, Dana C., Songbai Lin, John J. Brewington, et al.. (2019). Clinically approved CFTR modulators rescue Nrf2 dysfunction in cystic fibrosis airway epithelia. Journal of Clinical Investigation. 129(8). 3448–3463. 30 indexed citations

13.

Ambrosini, Yoko M., Dana C. Borcherding, Anumantha G. Kanthasamy, et al.. (2019). The Gut-Brain Axis in Neurodegenerative Diseases and Relevance of the Canine Model: A Review. Frontiers in Aging Neuroscience. 11. 130–130. 95 indexed citations

14.

Ben‐Jonathan, Nira, Dana C. Borcherding, Sejal R. Fox, & Eric R. Hugo. (2019). Activation of the cGMP/protein kinase G system in breast cancer by the dopamine receptor-1. Cancer Drug Resistance. 2(4). 933–947. 3 indexed citations

15.

Ambrosini, Yoko M., Dana C. Borcherding, Anumantha G. Kanthasamy, et al.. (2019). The Role of the Gut-Brain Axis in Neurodegenerative Diseases and Relevance of the Canine Model: A Review. Preprints.org. 2019010275. 1 indexed citations

16.

Borcherding, Dana C., Wilson Tong, Eric R. Hugo, et al.. (2015). Expression and therapeutic targeting of dopamine receptor-1 (D1R) in breast cancer. Oncogene. 35(24). 3103–3113. 72 indexed citations

17.

Borcherding, Dana C., et al.. (2011). Dopamine Receptors in Human Adipocytes: Expression and Functions. PLoS ONE. 6(9). e25537–e25537. 91 indexed citations

18.

Jacobson, Eric M., Eric R. Hugo, Dana C. Borcherding, & Nira Ben‐Jonathan. (2011). Prolactin in breast and prostate cancer: molecular and genetic perspectives.. PubMed. 11(59). 315–24. 28 indexed citations

19.

Borcherding, Dana C.. (2010). Human Adipocytes: Dopamine Receptors and the Regulation of Prolactin. OhioLink ETD Center (Ohio Library and Information Network). 1 indexed citations

20.

Hugo, Eric R., et al.. (2008). Prolactin Release by Adipose Explants, Primary Adipocytes, and LS14 Adipocytes. The Journal of Clinical Endocrinology & Metabolism. 93(10). 4006–4012. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact